Legal Representation
Attorney
Karin H. Butchko
USPTO Deadlines
Next Deadline
934 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-02-20)
Due Date
February 20, 2028
Grace Period Ends
August 20, 2028
Application History
32 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Sep 4, 2024 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
Sep 4, 2024 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
Sep 4, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Feb 14, 2024 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
Feb 20, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
Feb 20, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Dec 5, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Dec 5, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 15, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Nov 2, 2017 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 2, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Nov 2, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 2, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 2, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Nov 1, 2017 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
Oct 17, 2017 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
Sep 29, 2017 | ALIE | A | ASSIGNED TO LIE | Loading... |
Sep 15, 2017 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 15, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Sep 15, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 15, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 15, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Sep 9, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 8, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 8, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 31, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 31, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 31, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 24, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 2, 2017 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jun 1, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 29, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Providing a website featuring information on medical conditions, including their treatments and available public resources; providing a website featuring information in the field of drugs and medical products, namely, lists of potentially dangerous drugs and medical products, and Food and Drug Administration recalled drugs and recent news
First Use Anywhere:
Sep 1, 2014
First Use in Commerce:
Sep 1, 2014
Class 045
Providing a website featuring information in the field of class action lawsuit and settlement information; providing a website featuring legal information in the field of prescription drugs and medical products
First Use Anywhere:
Sep 1, 2014
First Use in Commerce:
Sep 1, 2014
Additional Information
Design Mark
The mark consists of the words "Drug Lawsuit Source" in blue lettering; to the left of the words is a design of a blue outlined flask partially filled with a black liquid. The flask is within a blue circle; four equally spaced black triangles are around the outside of the circle; a grey swirled motion effect or shape rises out of each of the triangles.
Color Claim
The color(s) blue, grey and black are claimed as a feature of the mark
Classification
International Classes
044
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DRUG LAWSUIT SOURCE"